Literature DB >> 15504603

Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study.

Marjolein W M van Ruijven1, John C M J de Groot, Guido F Smoorenburg.   

Abstract

We investigated the key tissues that are implicated in cisplatin ototoxicity within the time window during which degeneration starts. Guinea pigs were treated with cisplatin at a dose of 2 mg/kg/day for either 4, 6, or 8 consecutive days. Histological changes in the organ of Corti, the stria vascularis and the spiral ganglion were quantified at the light microscopical level. Outer hair cell (OHC) loss started between 4 and 6 days of cisplatin administration, but is only significantly different from the non-treated group after 8 days of treatment. Midmodiolar OHC counts were comparable to the cytocochleogram data. The cross-sectional area of the stria vascularis did not differ from the non-treated group, nor did an endolymphatic hydrops develop during the course of treatment. Spiral ganglion cell (SGC) densities did not decrease. After 6 days, however, detachment of the myelin sheath of the type-I SGCs was seen in the lower basal turn, whereas after 8 days it was also present in the more apically located turns. Myelin sheath detachment is the result of perikaryal shrinkage and swelling of the myelin sheath. The present study confirms that cisplatin at a daily dose of 2 mg/kg has a detrimental effect on the OHCs as well as on the type-I SGCs. These intracochlear effects occur simultaneously; OHC loss and SGC shrinkage start between the fourth and sixth day of cisplatin administration and appear to develop in parallel. At this dose, no histological effect on the stria vascularis could be observed, although previous electrophysiological experiments demonstrated a clear effect on the endocochlear potential

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504603     DOI: 10.1016/j.heares.2004.07.014

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  28 in total

1.  Cisplatin ototoxicity affecting cochlear implant benefit.

Authors:  Michael S Harris; Jaimie L Gilbert; Kelly A Lormore; Swapna A Musunuru; Michael H Fritsch
Journal:  Otol Neurotol       Date:  2011-08       Impact factor: 2.311

Review 2.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

3.  The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach.

Authors:  Sofia Waissbluth; Delphine Garnier; Olubunmi V Akinpelu; Pezhman Salehi; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-23       Impact factor: 2.503

Review 4.  Myelin development, plasticity, and pathology in the auditory system.

Authors:  Patrick Long; Guoqiang Wan; Michael T Roberts; Gabriel Corfas
Journal:  Dev Neurobiol       Date:  2017-09-26       Impact factor: 3.964

5.  Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.

Authors:  Susan Cheraghi; Parsa Nikoofar; Pedram Fadavi; Mohsen Bakhshandeh; Samideh Khoie; Elahe Jazayeri Gharehbagh; Saeid Farahani; Alireza Mohebbi; Maryam Vasheghani; Mahkameh Zare; Alireza Nikoofar; Seied Rabi Mehdi Mahdavi
Journal:  Med Oncol       Date:  2015-06-13       Impact factor: 3.064

6.  Cisplatin ototoxicity in rat cochlear organotypic cultures.

Authors:  Dalian Ding; Jingchun He; Brian L Allman; Dongzhen Yu; Haiyan Jiang; Gail M Seigel; Richard J Salvi
Journal:  Hear Res       Date:  2011-08-12       Impact factor: 3.208

7.  Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.

Authors:  Maryam Fouladi; Murali Chintagumpala; David Ashley; Stewart Kellie; Sridharan Gururangan; Tim Hassall; Lindsey Gronewold; Clinton F Stewart; Dana Wallace; Alberto Broniscer; Gregory A Hale; Kimberly A Kasow; Thomas E Merchant; Brannon Morris; Matthew Krasin; Larry E Kun; James M Boyett; Amar Gajjar
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

8.  Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.

Authors:  Sofia Waissbluth; Pezhman Salehi; Xinying He; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-21       Impact factor: 2.503

Review 9.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

Review 10.  Changes in the adult vertebrate auditory sensory epithelium after trauma.

Authors:  Elizabeth C Oesterle
Journal:  Hear Res       Date:  2012-11-20       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.